Mellanox Technologies, Ltd. (MLNX) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts MLNX Hot Sheet
Price: $124.89 --0%
Financial Fact:
Other income, net: 606K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Other income, net: 606K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Mellanox Technologies, Ltd. (NASDAQ: MLNX) reported Q4 EPS of $0.69, $0.04 better than the analyst estimate of $0.65. Revenue for the quarter came in at $122.1 million versus the consensus estimate of $120 million.
For earnings history and earnings-related data on Mellanox Technologies, Ltd. (MLNX) click here.
For earnings history and earnings-related data on Mellanox Technologies, Ltd. (MLNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
- Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
